株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国のペット用医薬品市場

Pet Medications in the U.S., 5th Edition

発行 Packaged Facts 商品コード 217051
出版日 ページ情報 英文 192 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.46円で換算しております。
Back to Top
米国のペット用医薬品市場 Pet Medications in the U.S., 5th Edition
出版日: 2017年08月25日 ページ情報: 英文 192 Pages
概要

米国のペット用医薬品の小売売上高は、2017年末までに86億米ドルに達すると予測されています。

当レポートでは、米国のペット用医薬品市場について調査分析し、現在の市場動向、小売販売の実績と予測、主要製品の競合戦略、消費者動向などについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 市場動向

  • 市場規模と構成
  • 市場の見通し
  • 将来の見通し

第3章 マーケターと製品

  • 競合概要
  • 小売ペット用医薬品マーケター
  • 寄生虫駆除:競合情勢
  • バイヤーのラインアップ
  • ZOETIS
  • ELANCO
  • VIRBAC
  • CEVA
  • BRAVECTO
  • CENTRAL GARDEN & PET
  • HARTZ
  • PERRIGO
  • PETIQ
  • 特許の戦い
  • フィラリア市場
  • 治療薬とワクチン
  • 脳の健康
  • 疼痛管理
  • 糖尿病
  • 心臓の健康
  • 耳の感染症
  • 皮膚アレルギー
  • 不安神経症
  • ワクチン
  • その他

第4章 販売動向

  • ペットオーナーのオプション
  • ペットの特殊性

第5章 消費者動向

  • ペット用医薬品の購入パターン
  • ノミ・ダニ駆除ブランドの人口統計
  • 犬オーナー世帯の67%がフィラリア薬を使用
  • ペット用医薬品に対する心理

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: LA15184172

Packaged Facts estimates that U.S. retail sales of pet medications will hit $8.6 billion by the end of 2017, inclusive of sales through veterinarians, brick-and-mortar stores, and online retailers, with sales growth even more robust than in 2016. The strong two-year increase reflects several blockbuster product introductions in the veterinary channel (including Zoetis' APOQUEL and Simparica, Merial's NexGard, and Merck's Bravecto), as well as weather conditions favorable to parasiticide sales.

The market for pet medications continues to show strong growth in the U.S. A raft of new products in the flea & tick category has redefined the landscape both in the veterinary market and in retail stores. Merial's growth has been spurred on by its success in chewable flea & tick, Nexgard, which it sometimes pairs with its heartworm product, Heartgard, to boost sales in both categories. Elanco's heartworm presence has increased as well, particularly due to aggressive marketing of Interceptor Plus to go along with its leading brand, Trifexis.

The pet medication industry has undergone consolidation, most notably with the closing of Boehringer Ingelheim's acquisition of Merial, making BI the second-largest player globally. Other significant deals included PetIQ's IPO and a large investment in Vets First Choice. The Vets First Choice investment points to the Internet's affect on pet meds distribution, ranging from mainstream channels such as Amazon, to Chewy.com as a pet product specialist, to pet drug-specific outlets such as 1-800-PetMeds.

Also factoring in are changes in the veterinary industry, including Mars' acquisition of VCA. Overall pet medication sales growth continues to be affected negatively by cheaper options for consumers (e.g., competition among Frontline Plus and its various imitators), particularly as they are sold in brick-and-mortar and online channels where margins are lower. However, the strong pipeline of patented prescription drugs is helping to keep price erosion at bay.

Scope:

In this fifth edition, Pet Medications in the U.S. analyzes the market for prescription and over-the-counter medications for dogs and cats, with a particular focus on brand-name products used by consumers. These include prescription, over-the-counter (OTC or “retail”), and ethical products (nonprescription medications whose distribution is restricted by the manufacturer to veterinarians). The primary focus of this report is on antiparasitics (flea, tick, heartworm, etc.), but it also covers market-shaping developments in other areas including cancer, cognitive dysfunction, mood disorder, pain management, and obesity/diabetes.

Animal health products for production animals and horses are excluded from this market analysis, as are nutritional supplements for horses and companion animals, the latter of which are covered in Packaged Facts' April 2017 report, Pet Supplements in the U.S., 6th Edition.

The report provides in-depth coverage of competitive trends, new product trends and marketing activity, and draws on insights from other reports in Packaged Facts' extensive Pet Market Collection. Data provided include historical and projected market revenues, along with demographics and psychographics of pet med purchasers, based on data from sources including Simmons and Packaged Facts' proprietary national pet owner surveys.

Report Methodology:

The information contained in this report was obtained from primary and secondary research. Primary research entailed informal interviews with leading manufacturers of pet medications and with other pet industry experts; attendance of the Global Pet Expo and Petfood Forum trade events from 2005 through 2017; consultations with pet product manufacturers and members of the trade; and an on-site examination of retail venues. Secondary research included extensive Internet canvassing and research- and data-gathering from relevant consumer business and trade publications; company reports including annual reports, press releases, and investor conference calls; company profiles in trade and consumer publications; government reports; and other pet market reports by Packaged Facts.

Sales estimates are based on published and estimated sales of major market participants; market size estimates from other sources appearing in the trade press; figures obtained through consultation with market participants; the performance of relevant retail venues; consumer usage rates for pet medications; rates of company and product entries into the market; and sales data from syndicated resources.

Our consumer analysis draws primarily on two sources:

  • Simmons National Consumer Surveys from Experian Marketing Services. On an ongoing basis, Experian Marketing Services conducts booklet-based surveys of a large and random sample of consumers (approximately 25,000 for each 12-month survey compilation) who in aggregate represent a statistically accurate cross-section of the U.S. population.
  • Packaged Facts Pet Owner Surveys, including one conducted in June/July 2017. These surveys had a sample of 2,000 U.S. respondents age 18 or over who in aggregate are representative of the primary demographic measures of gender, age bracket, race/ethnicity, geographic region, household income bracket, and presence of children in the household of the U.S. Census Bureau.

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

  • SCOPE AND METHODOLOGY
    • Market Definition
    • Report Methodology
  • MARKET TRENDS
    • Market Size & Composition
      • Table 1-1: Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2017 (percent)
  • MARKET OUTLOOK
    • Table 1-2: Projected U.S. Retail Sales of Pet Medications, 2017-2021 (in billions of dollars)
  • COMPETITIVE OVERVIEW
    • Prescription and Non-prescription Marketers
    • Global Animal Health Rankings Get Another Change
      • Table 1-3: Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2015-2016 (in millions of dollars)
  • RETAIL PET MEDICATION MARKETERS
    • Notable Deals
    • Chewables: The Next Generation
  • SALES TRENDS
    • Pet Owners Have Options
    • Veterinary Pharmacies Online
  • CONSUMER TRENDS
    • Most Dog or Cat Households Use Flea/Tick Products
    • Spot On Still on Top
    • 67% of Dog-Owning Households Use Heartworm Meds
    • Figure 1-1: Purchasing of Heartworm Medications by Channel, 2017 (U.S. dog owners)
    • Allergy Meds Top List of Other Pet Medications
    • Attitudes on Veterinarian/Professional vs. Store Products
      • Table 1-4: Levels of Agreement/Disagreement with Statement, “I Trust the Pet Medications My Veterinarian Recommends”: Dog Owners vs. Cat Owners, 2017 (percent)
  • MARKET OPPORTUNITIES
    • Opportunity 1 - Veterinary Consolidation
    • Opportunity 2 - Human/Animal Bond
    • Opportunity 3 - Veterinary Services Growth
    • Opportunity 4 - Exploring E-Commerce
    • Opportunity 5 - Generics Increasing Competition, and Spurring Innovation
    • Opportunity 6 - Millennials
    • Opportunity 7 - Chewable Tablets
    • Opportunity 8 - Combo Products
    • Opportunity 9 - Pet Ownership Growth

CHAPTER 2: MARKET TRENDS

  • MARKET SIZE & COMPOSITION
    • U.S. Retail Sales of Pet Medications at $8.6 Billion in 2017
      • Table 2-1: U.S. Retail Sales of Pet Medications, 2013-2017 (in billions of dollars)
    • Share of Sales by Animal Type
      • Figure 2-1: Share of U.S. Retail Sales of Pet Medications by Animal Type: Dog vs. Cat, 2017 (percent)
    • Share of Sales by Distribution Channel
      • Table 2-2: Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2017 (percent)
      • Table 2-3: Share of U.S. Sales of Pet Medications by Type, 2017 (percent)
  • MARKET OUTLOOK
    • The Veterinary Market
    • Higher-Income Households a Key Segment
      • Table 2-4: $70K+ Household Share of U.S. Pet Market Expenditures: By Category, 2009-2015 (percent)
    • The Human/Animal Bond
    • Humanization & Wellness
      • Table 2-5: Level of Agreement with Statement: “I am willing to pay more for pet food products that are healthier for my pets,” by Age Bracket, 2017 (percent)
    • Age of Pets
      • Table 2-6: Age of Dogs and Cats, 2017 (percent of pet owners)
    • Weighty Issues
      • Table 2-7: Agreement with Statement: “I have an overweight dog/cat,” 2016 vs. 2017 (percent)
    • Small Dogs Rule, but Medium Sizes Rebound
      • Table 2-8: Size of Pet Dogs, 2012-2017 (percent of dog owners)
      • Table 2-9: Size of Most Recently Acquired Pet Dog, 2014-2017 (percent of dog owners)
      • Illustration 2-1: Trade Ad for Metacam
    • Millennial Pet Owners
    • Ownership Trends
    • Funding from Morris Animal Foundation
    • A Third Spend Less
      • Table 2-10: Level of Agreement with Statement: “I am spending less on pet products because of the economy,” 2011-2017 (percent)
    • Economy Still Slow, but Many Indicators Show Positive Signs
      • Table 2-11: Economic Mood of U.S. Pet Households, 2013-2017 (percent)
      • Table 2-12: Economic Outlook of U.S. Pet Households, 2013-2017 (percent)
    • Veterinary Visits
      • Table 2-13: Percentage of Dog and Cat Owners Who Have Visited Vet in Last 12 Months for Routine and Sick/Emergency Vet Visits, 2016
    • Pet Owners Rely on Vet Advice
      • Table 2-14: Percentage of Dog and Cat Owners Who Rely on Their Veterinarian for Advice, by Topic of Advice, 2016
  • LOOKING AHEAD
    • Projected Market Growth: Sales to Crack $11 Billion by 2021
      • Table 2-15: Projected U.S. Retail Sales of Pet Medications, 2017-2021 (in billions of dollars)

CHAPTER 3: MARKETERS & PRODUCTS

  • COMPETITIVE OVERVIEW
    • Prescription & Non-prescription Marketers
    • Global Animal Health Rankings Gets Another Change
      • Table 3-1: Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2015-2016 (in millions of dollars)
      • Table 3-2: Global Pharmaceutical Marketers by Dollar and Percentage Change in Global Sales: Total vs.
    • Animal Health, 2015-2016 (in millions of dollars)
      • Table 3-3: Global Pharmaceutical Marketers by Dollar and Percentage Change in Global Sales: Animal Health, 2017 (projected) (in millions of dollars)
  • RETAIL PET MEDICATION MARKETERS
    • Notable Deals
      • Illustration 3-1 Trade Ad for Dechra's Amoxicillin Trihydrate and Clavulanate Potassium Tablets
    • Generics Increasing Competition, Spurring Innovation
    • Chewables: The Next Generation
  • PARASITICIDES - COMPETITIVE LANDSCAPE
    • Merial Brands Lead the Flea/Tick Charts
      • Table 3-4: Marketer Shares of U.S. Flea & Tick Sales, 2017 (percent)
    • Moving Forward with NexGard and Frontline
      • Illustration 3-2: Coupon Offer for Frontline Gold
      • Illustration 3-3: Screenshot of NexGardClinic.com
      • Illustration 3-4: Merial Pup Cup Event at 2017 NAVC Conference
  • BAYER'S LINEUP PACKS A PUNCH
    • Bayer's Channel Diversification
      • Illustration 3-5: Sponsored Ads on Google for Advantus
      • Illustration 3-6: Screen Shot from Advantage II for Cats TV Spot
  • ZOETIS EYES A BIGGER SLICE OF PARASITICIDE MARKET
    • Illustration 3-7: Screenshot from Simparica TV Ad
  • ELANCO'S GROWTH
  • VIRBAC'S OFFERINGS
    • Illustration 3-8: Screenshot of Virbac Rebates
  • CEVA PICKS UP GROWTH
    • Illustration 3-9: Trade Ad for Vectra 3D
    • Illustration 3-10: Trade Ad for Combiva II
    • Illustration 3-11: Ceva's Catego
  • BRAVECTO GUIDES MERCK ANIMAL HEALTH'S GROWTH
    • Illustration 3-12: Bravecto Marketing
  • CENTRAL GARDEN & PET
    • Illustration 3-13: Facebook Post About Adams' Amazon Dash Button
    • Illustration 3-14: Adams Rev Up VIP Racing Experience Sweepstakes
  • HARTZ
    • Illustration 3-15: Hartz Post on Facebook
  • PERRIGO LEADS GENERICS
  • PETIQ MAKES INROADS WITH OWN BRANDS
  • FIGHTING FOR YOUR PATENT
    • Illustration 3-16: Screenshot of 2015 PetAction Plus Ad
    • Illustration 3-17: Screenshot of PetArmor Plus Ad
    • Elanco
      • Illustration 3-18: Screenshot from Trifexis Ad
  • THE HEARTWORM MARKET
    • Virbac Sees Competitive Market
      • Illustration 3-19: Online Trade Ad for SENTINEL Spectrum
    • Elanco Adds Interceptor Plus to Lineup
      • Illustration 3-20: Trade Ad for Interceptor Plus
    • HEARTGARD Keeps Rolling
      • Illustration 3-21: Screen shot from TV Ad for Merial's HEARTGARD Plus
      • Illustration 3-22: Combo Buy Discounts for Merial Brands
      • Illustration 3-23: Trade Ad for HEARTGARD
    • Broad Spectrum Wormers
      • Illustration 3-24: Trade Ad for Drontal Plus
  • THERAPEUTICS AND VACCINES
    • Cancer
      • Illustration 3-25: Palladia
      • Illustration 3-26: Excerpt from Online Review of Masivet
  • BRAIN HEALTH
  • PAIN MANAGEMENT
    • Major Brands
      • Illustration 3-27: Ad for Patterson Veterinary's Levafen (Carprofen)
      • Illustration 3-28: Trade Ad for Norbrook's Loxicom
      • Illustration 3-29: Trade Ad for Bayer's Quellin
      • Illustration 3-30: Trade Ad for PREVICOX
      • Illustration 3-31: Banner Ad for RIMADYL
      • Illustration 3-32: Trade Ad for Galliprant
  • DIABETES
    • Illustration 3-33: Screenshot for Sugar & Spike Diabetes Website
    • Illustration 3-34: #PetHacks Diabetes Tweet by Merck
  • HEART HEALTH
    • Illustration 3-35: Trade Ad for Boehringer Ingelheim Vetmedica's VETMEDIN
  • EAR INFECTIONS
    • Illustration 3-36: Trade Ad for Merial's Tresaderm
    • Illustration 3-37: Trade Ad for Bayer Animal Health Claro
    • Illustration 3-38: Banner Ad for Baytril Otic
  • SKIN ALLERGIES
    • Illustration 3-39: Screenshot from APOQUEL TV spot
    • Illustration 3-40: Two-page Trade Ad for Cytopoint
    • Illustration 3-41: Search Ad for Cytopoint
    • Illustration 3-42: Trade Ad for Elanco's Itrafungol
  • ANXIETY
    • Figure 3-1: Pet Calming Product Usage, 2016 (percent of dog or cat owners)
    • Table 3-5: Purchase of Products to Relieve a Pet's Anxiety/Stress, Last 12 Months (percent of dog owners vs. cat owners)
    • Illustration 3-43: Sileo Noise Aversion Gel
  • VACCINES
    • Illustration 3-44: Trade Ad for Elanco's Ultra Vaccine Line
    • Illustration 3-45: Trade Ad for Nobivac
    • Illustration 3-46: Trade Ad for Duramune Lyme
  • OTHER PET MEDICATIONS
    • Illustration 3-47: Trade Ad for Dechra's ZYCORTAL

CHAPTER 4: SALES TRENDS

  • PET OWNERS HAVE OPTIONS
    • Online Sales
      • Table 4-1: Level of Agreement with Statement: “I am buying pet products online more than I used to,”2012-2017 (percent)
      • Table 4-2: Time Frame for Most Recent Online Purchase of Pet Products, 2012-2017 (percent of pet owners)
    • Vet-VIPPS Changes to the .Pharmacy Domain
    • Veterinary Pharmacies Online
      • Illustration 4-1: Trade Ad for Vets First Choice
      • Illustration 4-2: Screenshot of VetSource Website
    • Growth Improves for PetMed Express
      • Illustration 4-3: Banner Ad for 1-800-PetMeds
      • Table 4-3: PetMed Express Sales, 2007-2017 (in millions of dollars)
    • Petco Ups Its Pet Med Game
      • Illustration 4-4: Petco Drs. Foster & Smith Signage
    • Mass Market Retailers Emphasize Pet Meds
      • Illustration 4-5: TruProfen's Mass Market Purchase Locations
      • Illustration 4-6: Costco's Pet Medications Web Page
    • Veterinary Services Inside Pet Superstores
      • Table 4-4: Percentage of Dog or Cat Owners Who Have Taken Pets to a Pet Superstore for Veterinary Services in Last 12 Months, 2016 vs. 2017
      • Illustration 4-7: Vetco Page on Drs. Foster & Smith
    • Mobile Clinics
      • Table 4-5: Percentage of Dog or Cat Owners Who Have Visited a Mobile Veterinary Clinic in Last 12 Months, 2017
    • Fairness to Pet Owners Act
  • PET SPECIALTY HIGHLIGHTS FLEA & TICK
    • Illustration 4-8: Screenshot of Ad for Sentry Fiproguard Plus at PetSmart
    • Illustration 4-9: Flea & Tick Section from PetSmart Flyer, July 2017
    • Illustration 4-10: Flea & Tick Section from Petsense April-May 2017 Flyer

CHAPTER 5: CONSUMER TRENDS

  • PET MEDICATION PURCHASING PATTERNS
    • Most Dog or Cat Households Use Flea/Tick Products
      • Table 5-1: Percentage of Dog or Cat Owners Who Purchase Flea & Tick Care Medications or Medicated Products, 2014-2017 (U.S. dog- or cat-owning households in thousands)
    • Spot On Still on Top
      • Figure 5-1: Purchasing of Flea & Tick Care Medications: Share by Product Type, 2017 (percent of U.S. dog or cat owners)
      • Figure 5-2: Purchasing of Spot-On Flea & Tick Care Medications by Channel, 2017 (U.S. dog or cat owners)
    • Owners Choose Fipronil-Based Products
      • Table 5-2: Share of Flea & Tick Care Medication Purchasers by Brand, 2017 (U.S. dog owners)
      • Table 5-3: Share of Flea & Tick Care Topical Medication Purchasers by Brand, 2017 (U.S. cat owners)
  • DEMOGRAPHICS FOR FLEA & TICK BRANDS
    • Table 5-4a: Index for Use of Flea/Tick Products by Brand, 2017
    • Table 5-4b: Index for Use of Flea/Tick Products by Brand, 2017
  • 67% OF DOG-OWNING HOUSEHOLDS USE HEARTWORM MEDS
    • Table 5-5: Index for Use of Heartworm Control Medications for Dogs, 2017
    • Figure 5-3: Purchasing of Heartworm Medications by Channel, 2017 (U.S. dog owners)
    • Heartworm Brand Preferences
      • Table 5-6: Share of Heartworm Purchasers by Brand, 2017 (U.S. dog owners)
    • Allergy Meds Top List of Other Pet Medications
      • Table 5-7: Use by Type of Selected Other Pet Medications for Dogs and Cats, 2017 (percent)
      • Table 5-8: Purchasing by Channel of Selected Other Pet Medications for Dogs, 2017 (percent)
      • Table 5-9: Purchasing by Channel of Selected Other Pet Medications for Cats, 2017 (percent)
    • Key Brick-and-Mortar Channels
      • Table 5-10: Brick-and-Mortar Channel Choices for Pet Medications, Last Three Months, 2016 vs. 2017(percent of pet product buyers)
    • Flea/Tick Owners Favor Amazon
      • Table 5-11: Purchasing of Flea/Tick Products for Dogs by Online Source, 2017 (percent)
      • Table 5-12: Purchasing of Flea/Tick Products for Cats by Online Source, 2017 (percent)
  • PET MED PSYCHOGRAPHICS
    • Consistency of Pet Med Purchases Among Pet Owners
      • Table 5-13: Levels of Agreement/Disagreement with Statement, “I Am Buying More Pet Medications Than I Used To”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-14: Levels of Agreement/Disagreement with Statement, “The Current Range of Pet Medications Is Not Adequate”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-15: Levels of Agreement/Disagreement with Statement, “I Am Interested in New Types of Pet Medications”: Dog Owners vs. Cat Owners, 2017 (percent)
    • Age- and Weight-Related Issues Not a Purchase Driver
      • Table 5-16: Levels of Agreement/Disagreement with Statement, “Age-Related Conditions Are the Cause of Some of the Pet Medications That I Buy”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-17: Levels of Agreement/Disagreement with Statement, “Weight/Obesity-Related Conditions Are the Cause of Some of the Pet Medications That I Buy”: Dog Owners vs. Cat Owners, 2017(percent)
    • Attitudes on Veterinarian/Professional vs. Store Products
      • Table 5-18: Levels of Agreement/Disagreement with Statement, “I Trust the Pet Medications My Veterinarian Recommends”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-19: Levels of Agreement/Disagreement with Statement, “I Trust the Pet Medications Available at the Stores Where I Buy Pet Products”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-20: Levels of Agreement/Disagreement with Statement, “With Spot-On (Topical) Flea/Tick Products, the Products Available in Stores Are Just as Effective as Those Available Through Veterinarians”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-21: Levels of Agreement/Disagreement with Statement, “With Spot-On (Topical) Flea/Tick Products, I Would Trust Generic or Store-Brand Products if They Contained the Same Active Ingredients”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-22: Levels of Agreement/Disagreement with Statement, “Veterinarian-Dispensed Spot-On(Topical) Flea/Tick Products Are Too Expensive”: Dog Owners vs. Cat Owners, 2017 (percent)
    • Alternatives to Pet Meds
      • Table 5-23: Levels of Agreement/Disagreement with Statement, “I Avoid Using Pet Medications as Much as Possible”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-24: Levels of Agreement/Disagreement with Statement, “I Prefer to Try Holistic/Natural Pet Treatments Including Nutritional Supplements Before Resorting to Pet Medications”: Dog Owners vs. Cat Owners, 2017 (percent)
      • Table 5-25: Levels of Agreement/Disagreement with Statement, “High-Quality Pet Foods Are Effective as a Preventive Pet Health Treatment”: Dog Owners vs. Cat Owners, 2017 (percent)
Back to Top